Publication Name	World Journal of Stem Cells
Manuscript ID	64262
Country	Serbia

Category	Oncology
Manuscript Type	Review
Article Title	Immunotherapy in the treatment of lymphoma
Manuscript Source	Invited Manuscript
All Author List	Lazar S Popovic, Gorana Matovina-Brko, Maja Popovic, Milica Popovic, Ana Cvetanovic, Ivan Nikolic, Biljana Kukic and Dragana Petrovic
Funding Agency and Grant Number
Corresponding Author	Lazar S Popovic, MD, PhD, Professor, Department for Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Put dr Goldmana 4, Novi Sad 21000, Serbia. lazar.popovic@yahoo.com
Key Words	Immunotherapy; Receptors; Chimeric antigen; Antibodies; Monoclonal; Immunoconjugates; Hodgkin disease; Lymphoma; Large B-cell; Diffuse
Core Tip	Relapsed or refractory non-Hodgkin’s lymphomas, especially diffuse large B-cell lymphoma, are hard-to-treat diseases. Many immunotherapeutic options have changedthe course of treatment for different solid tumors. Here, we discuss the results, positions, practical aspects and future directions of different drugs and cellular therapies for the treatment of lymphoma.
Citation	Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells 2021; 13(6): 503-520

Received	2021-02-13 22:16
Peer-Review Started	2021-02-13 22:19
To Make the First Decision
Return for Revision	2021-03-17 01:07
Revised	2021-03-31 11:36
Second Decision	2021-05-08 08:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-08 08:55
Articles in Press	2021-05-08 08:55
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-27 17:58
Typeset the Manuscript	2021-06-23 13:28

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com